Position in LGND
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$4,311,242
+$852,775 QoQ
Shares Held
21,594
+18.1% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Derivatives in LGND
reported options exposure · as of Dec 31, 2020CallValue
$775,498
CallShares
12,500
PutValue
$390,851
PutShares
6,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $1,427,117,007 across 402 Biotechnology names. LGND ranks #41 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
682,807 | $304,900,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
184,691 | $142,699,654 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
263,375 | $87,142,884 | |
| 4 | MRNA |
Moderna, Inc.
|
1,480,034 | $75,185,727 | |
| 5 | FOLD |
AMICUS THERAPEUTICS, INC.
|
4,226,882 | $61,120,713 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
746,483 | $55,433,827 | |
| 7 | INCY |
Incyte Corp
|
489,649 | $46,085,763 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,536,110 | $42,550,246 |
All Filings in LGND
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,311,242 | 21,594 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,458,467 | 18,292 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,788,491 | 21,387 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $3,373,339 | 29,674 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $3,121,604 | 29,690 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,998,913 | 27,988 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,560,301 | 25,580 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,219,494 | 14,473 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $969,451 | 13,262 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $888,892 | 12,446 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $525,917 | 8,777 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $1,158,790 | 16,072 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $911,849 | 12,396 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $866,261 | 12,968 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $2,275,601 | 42,362 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,039,256 | 36,639 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,679,841 | 23,938 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $4,060,089 | 42,136 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $3,105,452 | 35,731 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $2,878,650 | 35,174 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $2,748,092 | 28,896 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $775,498 | 12,500 | Call | Defined | 2021-02-11 | |
| 2020-12-31 | $339,977 | 5,480 | Shares | Defined | 2021-02-11 | |
| 2020-12-31 | $390,851 | 6,300 | Put | Defined | 2021-02-11 | |
| 2020-09-30 | $134,148 | 2,256 | Shares | Defined | 2020-11-12 | |
| 2020-09-30 | $356,781 | 6,000 | Put | Defined | 2020-11-12 | |
| 2020-09-30 | $172,444 | 2,900 | Call | Defined | 2020-11-12 | |
| 2020-06-30 | $1,182,413 | 16,946 | Shares | Defined | 2020-08-12 | |
| 2020-06-30 | $809,394 | 11,600 | Put | Defined | 2020-08-12 | |
| 2020-06-30 | $544,248 | 7,800 | Call | Defined | 2020-08-12 | |
| 2020-03-31 | $430,966 | 9,500 | Call | Defined | 2020-05-12 | |
| 2020-03-31 | $276,725 | 6,100 | Put | Defined | 2020-05-12 | |
| 2020-03-31 | $1,155,216 | 25,465 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||